Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication

Ekaterina Dadachova; Scott G. Kitchen; Gregory Bristol; Gayle Cocita Baldwin; Ekaterina Revskaya; Cyril Empig; George B. Thornton; Miroslaw K. Gorny; Susan Zolla-Pazner; Arturo Casadevall

doi:10.1371/journal.pone.0031866

Loading metrics

Open Access

Peer-reviewed

Research Article

Pre-Clinical Evaluation of a ²¹³Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication

Ekaterina Dadachova ,

* E-mail: ekaterina.dadachova@einstein.yu.edu

Affiliation Albert Einstein College of Medicine, Bronx, New York, United States of America
⨯
Scott G. Kitchen,

Affiliation AIDS Institute, Division of Hematology/Oncology, The David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America
⨯
Gregory Bristol,

Affiliation AIDS Institute, Division of Hematology/Oncology, The David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America
⨯
Gayle Cocita Baldwin,

Affiliation AIDS Institute, Division of Hematology/Oncology, The David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America
⨯
Ekaterina Revskaya,

Affiliation Albert Einstein College of Medicine, Bronx, New York, United States of America
⨯
Cyril Empig,

Affiliation Pain Therapeutics, Inc., Austin, Texas, United States of America
⨯
George B. Thornton,

Affiliation Pain Therapeutics, Inc., Austin, Texas, United States of America
⨯
Miroslaw K. Gorny,

Affiliation Department of Pathology, New York University School of Medicine, New York, New York, United States of America
⨯
Susan Zolla-Pazner,

Affiliations Department of Pathology, New York University School of Medicine, New York, New York, United States of America, Veterans Affairs New York Harbor Healthcare System, New York, New York, United States of America
⨯
Arturo Casadevall

Affiliation Albert Einstein College of Medicine, Bronx, New York, United States of America
⨯

Pre-Clinical Evaluation of a ²¹³Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication

Ekaterina Dadachova,
Scott G. Kitchen,
Gregory Bristol,
Gayle Cocita Baldwin,
Ekaterina Revskaya,
Cyril Empig,
George B. Thornton,
Miroslaw K. Gorny,
Susan Zolla-Pazner,
Arturo Casadevall

Published: March 9, 2012
https://doi.org/10.1371/journal.pone.0031866

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
Radiolabeling
Is the Subject Area "Radiolabeling" applicable to this article?

Thanks for your feedback.
Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Cell binding
Is the Subject Area "Cell binding" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
Antibodies
Is the Subject Area "Antibodies" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Animal models of infection
Is the Subject Area "Animal models of infection" applicable to this article?

Thanks for your feedback.